Health Catalyst, GitLab, Elastic, and Marqeta Shares Plummet, What You Need To Know
Bloomberg reported Anthropic’s preliminary Q2 revenue exceeded $11.5B, and CNBC said software firms face pressure that AI coding tools could reduce software spending. Shares of Health Catalyst (HCAT), GitLab (GTLB), Elastic (ESTC) and Marqeta (MQ) fell in afternoon trading. Health Catalyst guided Q3 revenue to $55.5M and cut 2026 revenue to $247.5M midpoint.
How this was made
The 30-second read
Why it matters
The article links a broad afternoon selloff in software/data/payment names to AI monetization read-through, while Health Catalyst’s section adds company-specific guidance deterioration that likely explains a larger portion of its drawdown.
Market read
Traders can separate Health Catalyst’s guidance-driven repricing from the rest of the names that appear to be moving on AI software spend narrative risk.
What to watch
For Health Catalyst specifically, the article highlights sequential revenue decline and guidance cuts, but it does not discuss cost actions or pipeline conversion that could change the trajectory.
Background
Bloomberg and CNBC coverage is used to frame Anthropic’s preliminary Q2 revenue as proof that AI coding tools are generating real dollars, raising fears of hollowing out software bills.
Ticker impact
Health Catalyst shares fell 7% and the article cites a weak Q3 revenue forecast and reduced 2026 revenue guidance.
Near-term downside risk remains elevated until the company stabilizes sequential revenue and guidance trajectory.
The text provides specific Q3 and full-year guidance cuts plus the prior 23.1% drop on the earlier forecast reset, implying persistent market repricing.
GitLab shares dropped 4.5% in the afternoon session as the market reacted to Anthropic revenue news and AI tool monetization fears.
Choppy trading likely as the market continues to test whether AI coding tools translate into real budget shifts.
The article does not provide any GitLab-specific fundamental update, only that the stock was impacted alongside the group.
Elastic shares fell 3.9% as the article frames the selloff as evidence that AI coding tools are generating real dollars.
Limited company-specific edge; expect continued volatility tied to AI software spend narratives.
No Elastic-specific guidance, product, or financial datapoint is disclosed beyond the price move.
Marqeta shares dropped 3.8% in the afternoon session, grouped with other software names reacting to the Anthropic revenue report.
Near-term pressure likely to persist while the market debates AI-driven budget reallocation.
The text provides no Marqeta-specific new information, only that the stock was impacted.
Market effects
AI coding tool monetization is being treated as a real threat to software spend, pressuring multiple software and data infrastructure names.
Primarily US-listed software and data infrastructure complex, with spillover risk to broader growth/tech sentiment.
If the Anthropic revenue read-through persists, it can reinforce global AI software reallocation narratives and valuation compression.
Counterpoint
The group selloff may overstate direct competitive impact, since the article notes the market reaction could be an overreaction to news rather than a confirmed budget shift.
Key entities
- public_companyHealth Catalyst
HCAT fell 7% and the article cites a weak Q3 revenue forecast and reduced 2026 revenue guidance.
- public_companyGitLab
GTLB fell 4.5% with no company-specific update provided, implying read-through pressure.
- public_companyElastic
ESTC dropped 3.9% as part of the broader software selloff tied to AI tool monetization fears.
- public_companyMarqeta
MQ fell 3.8% in the same afternoon risk-off move, without a Marqeta-specific catalyst in the text.
